NARI Company Profile and Key Details

Q: Who are the executives of NARI?

Mr. Mitchell C. HillChief Financial OfficerMs. Dena TrueloveVice President of HRMr. Eric KhairySenior Vice President of MarketingDr. Thomas M. Tu M.D.Chief Medical OfficerMs. Janet BykVice President of Fin. & AccountingMr. Paul A. KoehnSenior Vice President of OperationsMr. Andrew J. HykesChief Executive Officer, Pres & DirectorMr. William H. HoffmanChief Executive Officer, Pres & DirectorMs. Angela AhmadGen. Counsel & Sec.Mr. John R. BorrellSenior Vice President of SalesMr. Brian StraussSenior Vice President of EngineeringMs. Tara DunnSenior Vice President of Clinical Affairs & Market Devel.

NASDAQ : NARI

Inari Medical

$79.97

At Close 4:00 PM

Not Actively Trading

77.26

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Inari Medical, Inc. (NARI) stock remained unchanged at $79.97 a share on NASDAQ. The stock opened at $79.96, fluctuating between $79.96 to $79.97 during the session.

Stock Snapshot

79.97

Prev. Close

4.68B

Market Cap

79.96

Day Low

-59.237037037037034

P/E Ratio

-1.35

EPS (TTM)

0.52

Cash Flow per Share

79.96

Open

58.56M

Number of Shares

79.97

Day High

91.09%

Free Float in %

8.07

Book Value

2.36M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 18, 2025	79.97	79.99	79.96	79.97	2.36M
Feb 14, 2025	79.94	79.97	79.93	79.93	1.01M
Feb 13, 2025	79.91	79.95	79.91	79.93	745.6K
Feb 12, 2025	79.86	79.95	79.86	79.92	1.59M
Feb 11, 2025	79.88	79.92	79.85	79.88	1.39M
Feb 10, 2025	79.90	79.90	79.84	79.86	790.18K
Feb 07, 2025	79.87	79.90	79.76	79.76	1.08M
Feb 06, 2025	79.87	79.90	79.83	79.87	760.2K
Feb 05, 2025	79.87	79.93	79.83	79.89	1.16M
Feb 04, 2025	79.87	79.89	79.82	79.85	1.58M
Feb 03, 2025	79.69	79.75	79.60	79.62	958.85K
Jan 31, 2025	79.70	79.73	79.61	79.67	758.46K
Jan 30, 2025	79.76	79.76	79.60	79.69	1.43M
Jan 29, 2025	79.65	79.76	79.56	79.70	989.52K
Jan 28, 2025	79.60	79.66	79.55	79.60	785.21K
Jan 27, 2025	79.75	79.75	79.56	79.62	664.33K
Jan 24, 2025	79.54	79.76	79.47	79.74	1.66M
Jan 23, 2025	79.46	79.60	79.40	79.46	1.56M
Jan 22, 2025	79.53	79.66	79.42	79.42	2.33M
Jan 21, 2025	79.54	79.61	79.44	79.50	2.94M

Contact Details

Irvine, CA 92618

United States

https://www.inarimedical.com 877 923 4747

About Company

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 BRKRP

-11.28-3.37%

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A$323.59 UFPT

0.92+0.36%

UFP Technologies, Inc.$256.21 PODD

-8.09-3.22%

Insulet Corporation$243.15 ALGN

14.32+8.88%

Align Technology, Inc.$175.62 IRTC

-5.71-3.75%

iRhythm Technologies, Inc.$146.75 TMDX

-0.77-0.59%

TransMedics Group, Inc.$129.60 IRMD

0.69+0.74%

IRadimed Corporation$94.54 AXNX

Axonics, Inc.$70.98 DXCM

-0.93-1.31%

DexCom, Inc.$69.89

Company Overview

The stock is currently trading near its 52-week high $36.73 and $79.99. With a market capitalization of about $4.68 billion, Inari Medical, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.03). Key stats such as the average daily volume over the past year has been around 2.44 million shares, in line with its 52-week average. Headquartered in Irvine, CA, Inari Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Kevin Strange, the company employs approximately 1,300 people and listed since May 22, 2020. Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 0.28%, SMA50 16.76%, SMA200 52.1%). The stock’s 14-day RSI is 79.6 (overbought), while the ATR of 0.7 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -0.02% below its high and over 117.72% above its low.

Valuation Metrics

Inari Medical, Inc. trades at a P/E ratio of -2775.03, slightly below the S&P 500 average, with a price-to-sales ratio of 9.49 and a price-to-book ratio of 9.77 trading at moderately above to book value. The P/FCF stands at 157.55, also above market averages.

Dividend & Fair Value

Inari Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$34.71. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Inari Medical, Inc. generated EPS of -$1.35 over the past year. Five-year average earnings growth is 32.83%. The latest quarter delivered EPS of $0.05. The next quarter is forecast at -$0.11. Next year's EPS is expected at -$70.15. Inari Medical, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended February 26, 2025, missed forecasts by -600.0%. The prior quarter beat by 8.33%. Over the last six quarters, Apple has recorded several small beats. These include 900.0% in January 10, 2024.

Shareholding & Insider Activity

Inari Medical, Inc. has 58.56 million shares outstanding. The public float is 53.37 million shares, elevated short interest at 5.07% of float. This equals 2.35 million shares. The short ratio is 0.54 days. Institutional investors hold 105.01% of the float. Insiders own 9.0%. MILDER DONALD B holds 3.03 million shares, Hykes Andrew has 439.31 thousand shares and Tu Thomas has 304.04 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Inari Medical generated $493.63M in revenue, or $8.70 per share. Gross margin was 86.86%, operating margin -0.74%, and net profit margin -0.33%. Returns are negative, with ROA at -0.24% and ROE at -0.35%.
On valuation metrics, Inari Medical trades at a P/E of -2775.03, P/S of 9.49 and P/B of 9.77. The current ratio is 3.09 and quick ratio is 2.52. Operationally, the company’s inventory turnover is 1.38 and cash conversion cycle is 251.58 days. Debt-to-equity is 0.07, supported by a cash flow-to-debt ratio of 1.12.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Inari Medical posted revenue of $493.63M, down slightly from $383.47M in the prior quarter. Gross profit was $428.76M (margin 86.86%). Operating income was - $3.63M (margin -0.7%). Net income was- $1.64M (EPS - $0.03).
The company ended the quarter with $116.06M in cash and short-term investments, a total debt of $32.05M, and net debt of - $7.16M. Total assets were $674.24M, with equity of $464.91M. Financials further reflected stability, with operating cash flow of $35.93M, free cash flow of $29.73M, and capital expenditures of - $6.20M.

Price Forecast & Outlook

Our AI price prediction model suggests that Inari Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.23%, with price expected at $82.55 by March 04, 2025, within a range of $76.41 to $89.08 3-Month Outlook: Projected fall of -17.64%, reaching $65.86 by May 19, 2025, with a range of $62.08 to $69.27. 1-Year Outlook: Projected loss of -9.34%, with price at $72.50 by February 18, 2026, within a range of $68.62 to $76.07.

Key Takeaways

Inari Medical, Inc. (NASDAQ:NARI) shares are up 56.65% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Inari Medical, Inc. trading at a premium to the broader market with a P/E of -2775.03. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $72.42, suggesting -9.44% downside. Our AI forecast model points to short-term strength (3.23% over two weeks), a medium-term fall (-17.64% over three months), and a longer-term loss (-9.34% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Inari Medical, Inc. (NARI) stock price?

Inari Medical, Inc. (NASDAQ: NARI) stock price is $79.97 in the last trading session. During the trading session, NARI stock reached the peak price of $79.97 while $79.96 was the lowest point it dropped to. The percentage change in NARI stock occurred in the recent session was 0% while the dollar amount for the price change in NARI stock was $0.00.

NARI's industry and sector of operation?

The NASDAQ listed NARI is part of Medical - Devices industry that operates in the broader Healthcare sector. Inari Medical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NARI?

Mr. Mitchell C. Hill
Chief Financial Officer
Ms. Dena Truelove
Vice President of HR
Mr. Eric Khairy
Senior Vice President of Marketing
Dr. Thomas M. Tu M.D.
Chief Medical Officer
Ms. Janet Byk
Vice President of Fin. & Accounting
Mr. Paul A. Koehn
Senior Vice President of Operations
Mr. Andrew J. Hykes
Chief Executive Officer, Pres & Director
Mr. William H. Hoffman
Chief Executive Officer, Pres & Director
Ms. Angela Ahmad
Gen. Counsel & Sec.
Mr. John R. Borrell
Senior Vice President of Sales
Mr. Brian Strauss
Senior Vice President of Engineering
Ms. Tara Dunn
Senior Vice President of Clinical Affairs & Market Devel.

How NARI did perform over past 52-week?

NARI's closing price is 117.72% higher than its 52-week low of $36.73 where as its distance from 52-week high of $79.99 is -0.03%.

How many employees does NARI have?

Number of NARI employees currently stands at 1,300.

Link for NARI official website?

Official Website of NARI is: https://www.inarimedical.com

How do I contact NARI?

NARI could be contacted at phone 877 923 4747 and can also be accessed through its website. NARI operates from 6001 Oak Canyon, Irvine, CA 92618, United States.

How many shares of NARI are traded daily?

NARI stock volume for the day was 2.36M shares. The average number of NARI shares traded daily for last 3 months was 2.44M.

What is the market cap of NARI currently?

The market value of NARI currently stands at $4.68B with its latest stock price at $79.97 and 58.56M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1300
Beta	1.03
Sales or Revenue	$493.63M
5Y Sales Change%	56.237%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

NARI Company Profile and Key Details

Inari Medical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics